BEAM WEALTH ADVISORS, INC. - CHINA SXT PHARMACEUTICALS IN ownership

CHINA SXT PHARMACEUTICALS IN's ticker is SXTC and the CUSIP is G2161P108. A total of 10 filers reported holding CHINA SXT PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BEAM WEALTH ADVISORS, INC. ownership history of CHINA SXT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$4,000
-60.0%
17,0000.0%0.00%
-60.0%
Q2 2020$10,0000.0%17,0000.0%0.01%0.0%
Q1 2020$10,000
-9.1%
17,000
+30.8%
0.01%0.0%
Q4 2019$11,00013,0000.01%
Other shareholders
CHINA SXT PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
Hudson Bay Capital Management LP 2,228,517$546,0000.01%
BEAM WEALTH ADVISORS, INC. 17,000$4,0000.00%
HRT FINANCIAL LP 328,435$80,0000.00%
Virtu Financial LLC 21,377$5,0000.00%
UBS Group AG 136,125$33,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
ACADIAN ASSET MANAGEMENT LLC 56,253$14,0000.00%
ExodusPoint Capital Management, LP 45,052$11,0000.00%
Renaissance Technologies 304,674$75,0000.00%
Hudock, Inc. 5,000$1,0000.00%
View complete list of CHINA SXT PHARMACEUTICALS IN shareholders